Clinical trial
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate…
NCT00006359 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00006359 |
|---|---|
| Title | Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer |
| Official title | Phase II Trial of Androgen Suppression for 6 Months Combined With External Beam Radiotherapy (EBRT) With Brachytherapy (BT) Boost for Intermediate Risk Prostate Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | LHRH agonist, antiandrogen, radiation therapy, Brachytherapy boost |
| Enrollment | 63 |
| Start date | Sep 1, 2000 |
| Primary completion | Oct 1, 2007 |
| Completion | Mar 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 18, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: